UK Regulator Wants More Patient/Public Involvement In Decision-Making

Input Requested Into New Innovative Licensing Pathway

In launching its latest consultation, the MHRA says it wants to see much more focus on the role of the ‘patient and public voice’ in shaping the way it makes regulatory decisions.

People figures with comment clouds above their heads
The MHRA wants to hear more from patients and the public • Source: Alamy

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced plans for involving patients and the public more closely and systematically in regulatory decision-making processes, committees and governance as part of its efforts to become a “patient focused regulator.”

Specific areas where the agency would like to see more public engagement include drug evaluations under the new Innovative Licensing...

More from United Kingdom

More from Europe